Article Details

Ionis Pharma Stock Is Trading Lower After Roche Drops Huntington's Disease Trial With Tominersen

Retrieved on: 2021-03-23 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

Ionis Pharma Stock Is Trading Lower After Roche Drops Huntington's Disease Trial With Tominersen. View article details on hiswai:

Excerpt

Roche also stopped dosing in an open-label extension study dubbed GEN-EXTEND dosing patients on the same high- and low-dose protocol. The ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo